Evidence map›Paper›PMID 28380057›Full record

ArticlePloS one2017

Specific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids.

Joshua Hakimian, Ani Minasyan, Lily Zhe-Ying, Mariana Loureiro, Austin Beltrand, Camille Johnston, Alexander Vorperian, Nicole Romaneschi, Waleed Atallah, Fernando Gomez-Pinilla and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Joshua HakimianDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Ani MinasyanDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Lily Zhe-YingBrain Research Institute, University of California Los Angeles, Los Angeles, California.
Mariana LoureiroDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Austin BeltrandDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Camille JohnstonDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Alexander VorperianDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Nicole RomaneschiDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Waleed AtallahDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.
Fernando Gomez-PinillaBrain Research Institute, University of California Los Angeles, Los Angeles, California.
Wendy WalwynDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, California.ORCID http://orcid.org/0000-0003-1192-3065
University of California, Los Angeles · US

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIANGDONG WILLIAM · 1987 to 2021
$30.7M
NIDA NIH HHS P50 DA005010
6 · The paper itself

Abstract

Opiates, one of the oldest known drugs, are the benchmark for treating pain. Regular opioid exposure also induces euphoria making these compounds addictive and often misused, as shown by the current epidemic of opioid abuse and overdose mortalities. In addition to the effect of opioids on their cognate receptors and signaling cascades, these compounds also induce multiple adaptations at cellular and behavioral levels. As omega-3 polyunsaturated fatty acids (n-3 PUFAs) play a ubiquitous role in behavioral and cellular processes, we proposed that supplemental n-3 PUFAs, enriched in docosahexanoic acid (DHA), could offset these adaptations following chronic opioid exposure. We used an 8 week regimen of n-3 PUFA supplementation followed by 8 days of morphine in the presence of this diet. We first assessed the effect of morphine in different behavioral measures and found that morphine increased anxiety and reduced wheel-running behavior. These effects were reduced by dietary n-3 PUFAs without affecting morphine-induced analgesia or hyperlocomotion, known effects of this opiate acting at mu opioid receptors. At the cellular level we found that morphine reduced striatal DHA content and that this was reversed by supplemental n-3 PUFAs. Chronic morphine also increased glutamatergic plasticity and the proportion of Grin2B-NMDARs in striatal projection neurons. This effect was similarly reversed by supplemental n-3 PUFAs. Gene analysis showed that supplemental PUFAs offset the effect of morphine on genes found in neurons of the dopamine receptor 2 (D2)-enriched indirect pathway but not of genes found in dopamine receptor 1(D1)-enriched direct-pathway neurons. Analysis of the D2 striatal connectome by a retrogradely transported pseudorabies virus showed that n-3 PUFA supplementation reversed the effect of chronic morphine on the innervation of D2 neurons by the dorsomedial prefontal and piriform cortices. Together these changes outline specific behavioral and cellular effects of morphine that can be reduced or reversed by dietary n-3 PUFAs.

Indexed as

AnimalsAnxietyCorpus StriatumDrug Administration ScheduleFatty Acids, Omega-3FemaleFrontal LobeLipidsLocomotionMaleMaze LearningMiceMice, Inbred C57BLMorphineMotor ActivityReal-Time Polymerase Chain ReactionFatty Acids, Omega-3LipidsMorphineReceptors, Glutamate

Identifiers

PMID28380057
PMCPMC5381919
OpenAlexW2604945962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.